Source comparison
Comparison of Metabolic Research Peptides
To provide more context, it's helpful to see how the AOD-9604 results timeline compares to other peptides used in Metabolic & Weight Research. Each has a unique mechanism and, therefore, a different timeline for observable effects. Primary Mechanism Stimulates
This comparison does not assign a generated winner or score.
- To provide more context, it's helpful to see how the AOD-9604 results timeline compares to other peptides used in Metabolic & Weight Research. Each has a unique mechanism and, therefore, a different timeline for observable effects.
- Primary Mechanism
- Stimulates lipolysis directly
- Central nervous system appetite suppressant
- Amylin analogue; slows gastric emptying
- Typical Onset
- Subtle metabolic shifts in 2-4 weeks
- Appetite effects within 1-2 weeks
- Satiety effects within days
- Peak Efficacy Window
- 9-12 weeks for significant fat loss
- 8-12 weeks for peak weight loss
- Sustained effect with continued use
- Primary Target
- Adipose tissue breakdown
- Appetite and food craving reduction
- Satiety and caloric intake control
- Considerations
- Requires consistency; slower onset
- CNS-based effects; potential for jitteriness
- GI-related side effects are possible
- Real Peptides Link
- AOD-9604
- Tesofensine Tablets
- Cagrilintide
- This table illustrates a critical point our team often makes: choosing the right tool depends on the research question. The AOD-9604 results timeline is distinct because its mechanism is so targeted at fat metabolism, whereas other compounds may produce faster but different types of results by targeting appetite or satiety.